532154 — Johnson Pharmacare Income Statement
0.000.00%
Last trade - 00:00
- IN₹434.50m
- IN₹453.56m
- IN₹25.27m
- 41
- 47
- 70
- 53
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 9.2 | 0 | 7.6 | 32.6 | 25.3 |
Cost of Revenue | |||||
Gross Profit | 0.2 | 0 | 1.1 | 5.71 | 5.05 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 9.31 | 0.918 | 7.58 | 31.3 | 23 |
Operating Profit | -0.109 | -0.918 | 0.016 | 1.34 | 2.23 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.109 | -0.918 | 0.016 | 1.34 | -13.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.109 | -0.918 | 0.012 | 0.967 | -12.9 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.109 | -0.918 | 0.012 | 0.967 | -12.9 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.109 | -0.918 | 0.012 | 0.967 | -12.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0 | -0.002 | 0 | 0.002 | -0.023 |